Hormone Zoomer (Female): A Clinical Case Report

This case simulation—grounded in patterns observed across hundreds of clinical consultations—is designed to support evidence-informed interpretation of the Hormone Zoomer (Female) Sample Report.

Clinical Narrative

A 39-year-old female (BMI 23.5) presenting with chronic fatigue, weight gain, irregular menstrual cycles with premenstrual spotting, mood swings, insomnia, and joint pain.

She works in a high-stress corporate role as a project manager and reports difficulty falling asleep due to racing thoughts, though she sleeps deeply once asleep. Her lifestyle includes regular weightlifting and a generally healthy diet, but also frequent use of conventional personal care products, plastic water bottles, black plastic cookware, plastic food storage containers, and a plastic dental night guard worn nightly.

Her history is notable for infertility, increasing stress levels, and progressively worsening PMS symptoms. At the time of testing, she also reported current use of DIM and a dietary supplement containing white peony and licorice.

Key Clinical Patterns

Pattern 1: HPA Axis Dysregulation and Altered Cortisol Metabolism

The most striking feature of the patient’s Hormone Zoomer results is the markedly elevated cortisol output across both saliva and urine testing, with an exaggerated cortisol awakening response (CAR) and persistently elevated cortisol production throughout the day.

• • Elevated saliva total cortisol
  • Elevated saliva waking cortisol
  • Elevated saliva waking + 60 minutes cortisol
  • Elevated urine 1st morning cortisol
  • Elevated urine free cortisol, pooled
  • Mid-range saliva total cortisone at waking, waking + 60 minutes, evening, and night
  • Elevated urine 1^st morning free cortisone
  • Elevated urine evening free cortisone
  • Elevated urine free cortisone pooled
  • Elevated urine cortisol:cortisone ratio

Elevated waking salivary cortisol and increased pooled urine free cortisol suggest sustained hypothalamic-pituitary-adrenal (HPA) axis activation and a persistent “fight-or-flight” physiology.

This pattern is commonly associated with:

• Chronic stress burden
• Sleep disruption
• Inflammation
• Overtraining
• Glycemic instability
• Ongoing psychosocial stressors

Although saliva cortisone levels remain within range, the elevated urinary cortisol:cortisone ratio may suggest altered cortisol metabolism and reduced peripheral conversion/inactivation of cortisol.

Clinical Implication:

Sustained cortisol exposure has been associated with:

• Mood swings

• Insomnia

• Central weight gain

• Sleep disruption
• Poor stress resilience
• Reproductive hormone suppression

Pattern 2: Supplement Influences on Cortisol and Hormone Metabolism

At the time of testing, the patient had been taking a dietary supplement containing white peony and licorice to support estrogen production.

White peony has been studied for its potential influence on aromatase activity and hormone metabolism, while licorice may inhibit 11β-HSD2, the enzyme responsible for converting active cortisol into inactive cortisone.

In individuals with elevated cortisol patterns, licorice may contribute to prolonged cortisol activity and altered cortisol:cortisone dynamics.

Clinical Considerations:
Licorice-containing protocols should be used cautiously in patients with:

• Elevated cortisol
• Hypertension
• Fluid retention
• Altered cortisol clearance patterns

Pattern 3: Estrogen Metabolism Shifted Toward the 2-OH Pathway

The patient’s Hormone Zoomer results demonstrated a strong preference for 2-hydroxylation within Phase 1 estrogen metabolism.

Findings include:

• Elevated 2-OH estrogen metabolites
• Relatively lower 4-OH and 16-OH metabolites
• Elevated 2-OH pathway proportion relative to total estrogen metabolism

This pattern is consistent with increased CYP1A1 pathway activity and may reflect the influence of DIM supplementation.

Clinical Considerations:

At first glance, preferential 2-OH metabolism is often viewed favorably due to reduced proliferative signaling compared with the 16-OH pathway. However, estrogen metabolism must be evaluated in the broader context of downstream detoxification and clearance capacity.

Pattern 4: Impaired Phase 2 Methylation and Estrogen Clearance

Despite robust Phase 1 estrogen metabolism, the patient’s results suggest incomplete downstream clearance of activated estrogen metabolites.

Key findings include:

• Accumulation of unmethylated estrogen metabolites
• Reduced methylation efficiency
• Elevated oxidative stress marker 8-OHdG (13.76)

This creates a functional bottleneck in which estrogen metabolites are successfully activated during Phase 1 detoxification but are not efficiently neutralized and eliminated during Phase 2 metabolism.

Clinical Implications:

This pattern may contribute to:

• Oxidative stress
• Accumulation of reactive intermediates
• Cellular stress and DNA damage
• Increased detoxification burden

Elevated 8-OHdG further supports increased oxidative stress and oxidative DNA damage.

Pattern 5: Altered Progesterone Metabolism and Neuroactive Steroid Balance

Although several progesterone metabolites remain within reference range, the patient’s results demonstrate altered downstream progesterone metabolism patterns.

Key findings include:

• Approximately threefold elevation in β-pregnanediol
• Elevated β-pregnanediol/E2 ratio
• Low allopregnanolone
• Borderline low 3α-dihydroprogesterone
• Borderline low 20α-dihydroprogesterone
• Low-normal α-pregnanediol

This pattern suggests relatively elevated progesterone metabolite activity compared with estradiol, while also indicating reduced downstream conversion into certain neuroactive progesterone metabolites.

Clinical Implications:

Neuroactive progesterone metabolites play important roles in:

• GABAergic signaling
• Mood regulation
• Stress resilience
• Sleep quality

Reduced downstream conversion may contribute to symptoms such as:

• Irritability
• Mood swings
• PMS symptoms
• Sleep disruption
• Reduced stress tolerance

This case highlights the importance of evaluating not only absolute hormone levels, but also downstream metabolic pathways and functional hormone signaling.

Pattern 6: Endocrine Disruptor Burden

The patient’s results demonstrated elevated levels of several endocrine disruptors, including:

• BPA
• Glyphosate

Combined with her reported exposures:

• Plastic water bottles
• Black plastic cookware
• Plastic storage containers
• Plastic dental night guard
• Conventional personal care products

These findings suggest a meaningful exogenous endocrine disruptor burden.

Clinical Relevance:

BPA exhibits estrogenic activity and may interfere with normal endocrine signaling, while glyphosate exposure has been associated with microbiome disruption, oxidative stress, and impaired detoxification pathways.

Pattern 7: Preserved Bone Health Markers

Bone health markers remained within range, consistent with the patient’s regular resistance training and weightlifting routine.

This represents an important protective factor in the setting of chronic stress and hormonal dysregulation.

Clinical Interpretation

The patient’s Hormone Zoomer results demonstrate a complex, multi-system pattern involving:

1. Chronic Stress Physiology and HPA Axis Overactivation

• Elevated cortisol production
• Exaggerated cortisol awakening response
• Altered cortisol:cortisone dynamics

2. Estrogen Detoxification Imbalance

• Strong Phase 1 estrogen activation
• Incomplete Phase 2 methylation and clearance
• Elevated oxidative stress burden

3. Altered Neuroactive Progesterone Metabolism

• Reduced downstream progesterone metabolite conversion
• Potential impacts on mood, sleep, and stress resilience

4. Environmental Endocrine Disruptor Exposure

• Elevated BPA and glyphosate
• Multiple ongoing environmental exposures

Why This Case Matters

This case highlights several important clinical principles:

• Elevated cortisol patterns may reflect both stress burden and altered cortisol metabolism
• Estrogen metabolism should be evaluated in the context of both Phase 1 activation and Phase 2 clearance
• Neuroactive progesterone metabolites may influence mood, sleep, and stress resilience even when progesterone appears “normal”
• Dietary supplements and botanicals can meaningfully influence hormone metabolism pathways
• Environmental toxicant exposures may contribute to endocrine dysregulation and oxidative stress

Key Takeaways